10.1016/j.ejim.2024.01.005 5 ArmstrongM
GLP-1, GIP, and exenatide seem to have the same patterns here: Phe 22 is centered to specifically interact with the receptor and the adjacent hydrophobic residues of positions 23, 25, and 26 are used to form a hydrophobic region
[1] GLP-3 represents a novel generation of research compounds in the anti-obesity and antidiabetic field, characterized by its unique mechanism of action involving the simultaneous activation of three metabolically relevant receptors: the GCG-like peptide-1 receptor (GLP-1R), the glucose-dependent insulinotropic polypeptide receptor (GIPR), and the GCG receptor (GCGR)
Half-Life: ~6 days
It is whether a qualified clinician obtained enough information to decide that the medication is appropriate, prescribed a reliable product, and remained available to manage what happens next
The reduced risk was consistent when studying only patients with Type 2 diabetes (RR 0.54) or patients without diabetes (RR 0.52)